BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1290396)

  • 1. [Parkinson syndrome, a possible adverse effect of calcium inhibitors].
    Malaterre HR; Lauribe P; Paganelli F; Ramond B; Lévy S
    Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1335-7. PubMed ID: 1290396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonian syndrome and calcium channel blockers.
    Prescrire Int; 2003 Apr; 12(64):62. PubMed ID: 12674122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson syndrome from diltiazem].
    Remblier C; Kassir A; Richard D; Pérault MC; Guibert S
    Therapie; 2001; 56(1):57-9. PubMed ID: 11322019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse reactions associated with calcium channel blockers.
    Stern R; Khalsa JH
    Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
    Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
    J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible interaction between lithium and diltiazem: case report.
    Valdiserri EV
    J Clin Psychiatry; 1985 Dec; 46(12):540-1. PubMed ID: 4066622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal pseudo-obstruction caused by diltiazem in a neutropenic patient.
    Young RP; Wu H
    Ann Pharmacother; 2005 Oct; 39(10):1749-51. PubMed ID: 16144882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecomastia associated with calcium channel blocker therapy.
    Tanner LA; Bosco LA
    Arch Intern Med; 1988 Feb; 148(2):379-80. PubMed ID: 3341839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
    Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
    Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil.
    Miranda J; Brunet L; Roset P; Berini L; Farré M; Mendieta C
    J Clin Periodontol; 2005 Mar; 32(3):294-8. PubMed ID: 15766373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
    Boyd IW
    Med J Aust; 1994 Sep; 161(5):328. PubMed ID: 7830672
    [No Abstract]   [Full Text] [Related]  

  • 16. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
    Zeltser D; Justo D; Halkin A; Rosso R; Ish-Shalom M; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2004 Jul; 44(1):105-8. PubMed ID: 15234417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Side-effects of calcium inhibitors].
    Lavarenne J
    Therapie; 1989; 44(3):197-200. PubMed ID: 2675381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-channel blockers and gingival hyperplasia.
    Tam IM; Wandres DL
    Ann Pharmacother; 1992 Feb; 26(2):213-4. PubMed ID: 1554935
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
    Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
    Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.